COSCIENS Biopharma Inc
TSX:CSCI

Watchlist Manager
COSCIENS Biopharma Inc Logo
COSCIENS Biopharma Inc
TSX:CSCI
Watchlist
Price: 2.9 CAD -2.03% Market Closed
Market Cap: 9.4m CAD

Intrinsic Value

The intrinsic value of one CSCI stock under the Base Case scenario is 7.08 CAD. Compared to the current market price of 2.9 CAD, COSCIENS Biopharma Inc is Undervalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CSCI Intrinsic Value
7.08 CAD
Undervaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
COSCIENS Biopharma Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CSCI?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CSCI valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for COSCIENS Biopharma Inc.

Explain Valuation
Compare CSCI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CSCI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
COSCIENS Biopharma Inc

Current Assets 13.8m
Cash & Short-Term Investments 8.5m
Receivables 1.6m
Other Current Assets 3.7m
Non-Current Assets 10m
PP&E 9.9m
Other Non-Current Assets 132k
Current Liabilities 4m
Accounts Payable 1m
Accrued Liabilities 918k
Other Current Liabilities 2m
Non-Current Liabilities 14.8m
Long-Term Debt 2m
Other Non-Current Liabilities 12.8m
Efficiency

Free Cash Flow Analysis
COSCIENS Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
COSCIENS Biopharma Inc

Revenue
9.1m USD
Cost of Revenue
-5m USD
Gross Profit
4.1m USD
Operating Expenses
-15.7m USD
Operating Income
-11.6m USD
Other Expenses
-3.3m USD
Net Income
-14.9m USD
Fundamental Scores

CSCI Profitability Score
Profitability Due Diligence

COSCIENS Biopharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Healthy Gross Margin
23/100
Profitability
Score

COSCIENS Biopharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

CSCI Solvency Score
Solvency Due Diligence

COSCIENS Biopharma Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Low D/E
Long-Term Solvency
57/100
Solvency
Score

COSCIENS Biopharma Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CSCI Price Targets Summary
COSCIENS Biopharma Inc

There are no price targets for CSCI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

COSCIENS Biopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CSCI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CSCI stock?

The intrinsic value of one CSCI stock under the Base Case scenario is 7.08 CAD.

Is CSCI stock undervalued or overvalued?

Compared to the current market price of 2.9 CAD, COSCIENS Biopharma Inc is Undervalued by 59%.

Back to Top